Navigation Links
Gene variations explain drug dose required to control seizures

Determining which variants of particular genes patients with epilepsy carry might enable doctors to better predict the dose of drugs necessary to control their seizures, suggest basic findings by researchers at the Duke University Institute for Genome Sciences & Policy (IGSP) and the University College London. Patients often undergo a lengthy process of trial and error to find the dose of anti-epilepsy drugs appropriate for them.

The researchers found that variants of two genes were more likely to be found in patients who required higher dosages of anti-epileptic drugs.

The findings suggest that, by incorporating genetic tests into the prescription process, physicians might improve outcomes for patients with epilepsy, said the researchers. A similar approach might also prove useful for other conditions, such as Parkinson's disease and cancer, in which patients' drug dosage requirements vary substantially, they added.

Rigorous clinical study is required before any such method could be put into practice, the researchers emphasized.

In the March 28, 2005, early edition of Proceedings of the National Academy of Sciences, the investigators report the first clear evidence linking variation in genes involved in the action or metabolism of the anti-epileptic drugs, carbamazepine and phenytoin, to the drugs' clinical use. The study is the first to emerge from a partnership, aimed at tailoring the treatment of epilepsy to patients' genetic makeup, between the Department of Clinical and Experimental Epilepsy at the University College London and the Duke Center for Population Genomics and Pharmacogenetics, a center of the IGSP.

If the genes' predictive value is verified in clinical trials, such a "pharmacogenetic" approach might make it possible to safely reduce the time required for patients with epilepsy and their physicians to reach an effective dose of the medications that control seizures, said David Goldstein, Ph.D., director of
'"/>

Source:Duke University Medical Center


Page: 1 2 3 4

Related biology news :

1. Researchers map of genetic variations implicated in disease
2. A new kind of mutation could explain numerous phenotypic variations in various species
3. Gene variations contribute to aggression and anger in women
4. Jumping gene helps explain immune systems abilities
5. Gene sequencing explains bioremediation bug
6. Variation in womens X chromosomes may explain differences among individuals, between sexes
7. Iron exporter revealed that may explain common human disorder
8. New book explains antibiotic resistance for a broad audience
9. Cats indifference towards sugar explained
10. Monkeypox mystery: New research may explain why 2003 outbreak in the US wasnt deadly
11. Scientist uses form to explain function of key building blocks of life

Post Your Comments:
(Date:11/25/2009)...OVEMBER 25, 2009 Soil is the linchpin of the envi...ere meet. Despite that, many students see soil as ...ore. Soil science educators are challenged with th...e the critical importance of soil in the environme...nd earth science teachers at University of Nebrask...
(Date:11/24/2009)...of years it has been prescribed by traditional hea...eadaches and stomach pain to fever and flu. , Now...ersity have been able to scientifically prove the ...erwise known as Brazilian mint. , Testing this an... researcher Graciela Rocha was able to show that w...
(Date:11/24/2009)...ep weakened and flabby arteries from collapsing ha...ose stents are no longer needed -- once the arteri...iously, doctors had no choice but to leave them in...versity,s Department of Biomedical Engineering has...t carries drugs where they,re needed, then dissolv...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Too Much Computer Gaming Can Steal Your Sleep 48151 1Too Much Computer Gaming Can Steal Your Sleep 48151 2Too Much Computer Gaming Can Steal Your Sleep 48151 3D Pharm Receives FDA Clearance to Commence a Phase III Trial of DP b99 in Acute Stroke Patients 12510 1D Pharm Receives FDA Clearance to Commence a Phase III Trial of DP b99 in Acute Stroke Patients 12510 2D Pharm Receives FDA Clearance to Commence a Phase III Trial of DP b99 in Acute Stroke Patients 12510 3Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 1Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 2Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 3Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 4
...ass. -- A pioneering study of wild chimpanzees has...tinely experience menopause, rebutting previous st...that female chimpanzees reach reproductive senesce...ent data from wild gorillas and orangutans, the fi...t Biology -- suggests that human females are rare ...
...tral, the Open Access publisher for Physics, Mathe...rship agreements with the CERN and DESY high-energ...e organizations will centrally cover article-proce...investigators in the peer-reviewed open access jou... professor Ken Peach of University of Oxford and R...
....Y., December 13, 2007 Nutrition 21, Inc. (NASDAQ...ium-based and omega-3 fish oil-based nutritional s...cal study that showed daily supplementation with 1...d cognitive function in older adults experiencing ...d, double-blind, placebo-controlled study were pre...
Other Biology News:Wild chimpanzees appear not to regularly experience menopause 2Top physics laboratories sign up to open access with PhysMath Central 2New clinical data shows chromium picolinate improves cognitive function 2New clinical data shows chromium picolinate improves cognitive function 3
(Date:11/24/2009)...RNewswire-Asia/--NODPharmaceuticalsInc.announced,t...tentapplicationfor,itsnano-particleoraldeliveryorN...ntapproachtoincorporatepeptidesor,proteinsintobio-...otherwiseadministeredasinjections.NODtechnologyisa...culardrugssuchasinsulin,interferon,growthhormone,...
(Date:11/24/2009)...Newswire/--BlueMarbleEnergyCorp.announcedtodaythat...PDA)wererecentlyawarded$2millionbyWashingtonState,...ate/publicpartnershiptoconstructthestate,sfirstspe..., "Thisinvestmentwillsignificantlyspeedthedevelo...olnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."We...
(Date:11/24/2009)..., TORONTO,Nov.24/PRNewswire-FirstCall/-Hamilton...leadingproviderofadvancedlasersystemsandinstrument...odayreportedoperationalandfinancialresultsfortheth...hts,-Revenuewas$1.46millioncomparedwith$1.43milli...dwith66.1percentinQ3,2008,-Netlossreducedto$148,00...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc....cHealth,sExecutiveChairman,willpresentatthe21stAnn...Tuesday,December1,2009at10:00a.m.ET. ,, Toacces...ation,visittheInvestorRelationssectionofGenomicHea...Pleaseconnecttothewebsiteatleast15minutespriortoth...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ech businesses will soon have a chance to network ...n. , ,The Japan External Trade Organization, or JE...leges and corporations to Japan this September 25 ...conferences, visit research centers and network wi...just this March led a trade mission to China, will...
...eceived a two-year Phase II Small Business Innova...tal 2004 SBIR funding to $3.29 million, the compan...rch Projects Administration gives SBIR funding to...elopment. Platypus, award is the typical maximum a...ill use the money to develop a prototype of a rapi...
...ource: Imago MADISON, Wis. Mass storage vendor ...adison-based Imago Scientific Instruments to mee...d hard drives. , ,Imago announced Tuesday that Sea...e analytical tool for the development of advanced ...o the company, The LEAP Microscope has proven succ...
Other Biology Technology:40 Midwest biotech organizations to explore Japanese partnerships 240 Midwest biotech organizations to explore Japanese partnerships 340 Midwest biotech organizations to explore Japanese partnerships 4Platypus keeps gathering federal funding with $750,000 for defense research 2
Rabbit Anti-Human TRIB1 / SKIP1 / Tribbles 1 Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Pim-1 Monoclonal Antibody, Unconjugated, Clone 12H8 from Santa Cruz Biotechnology, Inc.
Rabbit Anti-Human Ets-1 Antibody, Unconjugated from Spring Bioscience
Mouse Anti-Desmoglein 1 Monoclonal Antibody, Unconjugated, Clone 3G131 from Abcam
Biology Products: